2014
DOI: 10.1016/j.wneu.2014.07.027
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive Management of the Paranasal Sinuses in Patients Undergoing Endoscopic Endonasal Skull Base Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 18 publications
(19 citation statements)
references
References 20 publications
0
19
0
Order By: Relevance
“…ESBS patients differ from chronic rhinosinusitis patients in that they presumably have lower rates of olfactory dysfunction and sinonasal morbidity prior to surgery . Thus, it is important to examine the ESBS cohort as a distinct group of patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…ESBS patients differ from chronic rhinosinusitis patients in that they presumably have lower rates of olfactory dysfunction and sinonasal morbidity prior to surgery . Thus, it is important to examine the ESBS cohort as a distinct group of patients.…”
Section: Introductionmentioning
confidence: 99%
“…10 ESBS patients differ from chronic rhinosinusitis patients in that they presumably have lower rates of olfactory dysfunction and sinonasal morbidity prior to surgery. 5,11 Thus, it is important to examine the ESBS cohort as a distinct group of patients. A few prior prospective and retrospective studies have examined subjective and objective olfactory outcomes in ESBS patients, all with conflicting results.…”
Section: Introductionmentioning
confidence: 99%
“…FESS was concurrently performed at the time of TSH in 15% of patients who developed post‐TSH rhinosinusitis, compared to 10% of patients without post‐TSH rhinosinusitis, which did not reach statistical significance. In cases of chronic rhinosinusitis or a history of recurrent acute rhinosinusitis in the absence of active infection, we believe it is safe to perform FESS concurrently with TSH . However, in the presence of acute bacterial infection or presence of fungal mycetoma, it is advised to medically treat the patient or perform staged FESS prior to TSH …”
Section: Discussionmentioning
confidence: 99%
“…In cases of chronic rhinosinusitis or a history of recurrent acute rhinosinusitis in the absence of active infection, we believe it is safe to perform FESS concurrently with TSH. 15 However, in the presence of acute bacterial infection or presence of fungal mycetoma, it is advised to medically treat the patient or perform staged FESS prior to TSH. 15 Significant differences in BMI were noted between patients who developed post-TSH rhinosinusitis after 3 months (mean BMI 34.3 kg/m 2 ) and those who did not develop post-TSH rhinosinusitis (mean BMI 30.4 kg/m 2 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation